SPOTLIGHT -
Psychedelics Research Roundup: September 22
What is new in research on psychedelics?
Attention to Attention is What You Need: Artificial Intelligence and Medicine
Here's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.
Safety Planning: A Tool for Peers As Well?
Safety planning by peers is feasible and acceptable to patients, might result in decreased ED visits, and may represent a way of implementing safety plans in rural EDs.
Violence Risk Assessment in the Emergency Department
"As society continues to grapple with the consequences of violent behaviors, increasing efforts to understand and mitigate the risks of such behaviors using evidence-based methods and tools will be essential."
World Peace Day and Psychiatry
Today, spread peace.
World Alzheimer's Day 2023
Today is World Alzheimer's Day!
Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD
The investigators noted fast, clinically meaningful, and sustained improvements in symptoms of depression and related functional impairment.
Emergency Psychiatry in an Extraordinary Age
Welcome to the Emergency Psychiatry Special Report.
Antipsychotic Medication for Parkinson Disease Psychosis Receives Packaging Label Updates
The drug’s developer announced that the FDA has made 2 clarifying revisions.
Psilocybin Plus SSRIs for Treatment-Resistant Major Depression
Do SSRIs impact on the antidepressant efficacy of psilocybin? Researchers performed an open-label trial of single-dose psilocybin in patients with TRD who were taking SSRIs.
Examining Malpractice Risk to Physicians
An estimated 31% of physicians have been sued at some point in their careers. Here's what you need to know.
Physical and Mental Imprisonment
Is excess imprisonment a uniquely American problem?
Girls and Their Monsters, Part 3
Here’s what the historic case of the Genain quadruplets reveals about some deeper, uncomfortable truths about American society.
How Do Treatments for Bipolar Disorder and SUD Affect One Another?
An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.
The Future of Clinical Trials: Diversity, Transparency, and Reform
How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?
PTSD
"For months she has dreamed in red..."
Some 2023 Ig Nobel Prize Winners
Awarding laughter… check out these past Ig Nobel Prize winners.
The Week in Review: September 11-15
From the efficacy of adjunctive TMS for treatment-resistant major depression to a look at adult ADHD, here are highlights from the week in Psychiatric Times.
Developing Effective Treatment Strategies for Women With Schizophrenia
The presentation of schizophrenia differs significantly between men and women. Here's what you need to know.
Special Populations Research Roundup: September 15
What is new in research on psychiatric care for Latinx patient populations?
Celebrating Hispanic Heritage Month 2023
September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.
New Travel Log: Artistic Collaborations in the Arts and in Psychiatry
Arts and psychiatry: better at collaboration than most.
The “10 Knows” Psychiatric Clinicians Need to Prepare for a Job Interview
What 10 things do you need to know before entering a job interview?
Summer Breeze & Intimations of Mortality
As we say goodbye to summer…
New Travel Log: Please Astonish Us
What astonishes you?
Collaborating Saves Lives
"Collaborative care quality initiatives may have become an insurance industry buzzword, but the true spirit of collaborating to save lives has always lived within clinicians."
EMPOWERing the Next Generation
An expert discusses recent research evaluating a selective M4 positive allosteric modulator for the treatment of schizophrenia.
Psychodynamic Telepsychiatry After the Pandemic
Let’s take another look at telepsychiatry.
Meta-Analysis of Adjunctive TMS in Treatment-Resistant Major Depression
Adjunctive rTMS for treatment-resistant depression? Researchers performed a meta-analysis of 19 randomized sham-controlled trials.
Keeping Up With the Times
Have you registered for the 2023 Annual Psychiatric Times World CME Conference?